← Back to Search

Digital Application

AF CARE for Atrial Fibrillation (AFCARE Trial)

N/A
Waitlist Available
Led By Linda Ottoboni, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to ambulate
BMI greater than 28 kg/m2 and one additional CVRF using LS7
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 3, month 6, and month 12
Awards & highlights

AFCARE Trial Summary

This trial is testing a new program to help people with AF improve their lifestyle and manage their symptoms. The goal is to see if it is feasible and effective.

AFCARE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are able to walk.
Select...
Your body mass index (BMI) is higher than 28 kg/m2 and you have at least one additional risk factor for cardiovascular disease (such as high blood pressure, high cholesterol, or smoking) as determined by a tool called LS7.
Select...
You have the ability and willingness to use digital technology.

AFCARE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 3, month 6, and month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 3, month 6, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cardiovascular Risk Factor Score
Percentage of Emails Opened and Clicked Through
Percentage of Text Messages That Were Reviewed
Secondary outcome measures
Change From Baseline in AF Quality of Life Score
Change From Baseline in AF Symptom Burden
Change From Baseline in AF Symptom Severity
+1 more

AFCARE Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Pilot TestingExperimental Treatment1 Intervention
Patients interface with the digital application, providing feedback on usability and satisfaction.
Group II: Usual Care then AF CareActive Control1 Intervention
After a 6 month period of usual care only, patients will interface with the digital application.
Group III: AF CARE plus Usual CareActive Control2 Interventions
Patients will interface with the digital application.

Find a Location

Who is running the clinical trial?

PatientBondUNKNOWN
American Heart AssociationOTHER
319 Previous Clinical Trials
4,932,411 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
92,326 Patients Enrolled for Atrial Fibrillation
Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,916 Total Patients Enrolled
18 Trials studying Atrial Fibrillation
425,634 Patients Enrolled for Atrial Fibrillation

Media Library

AF CARE (Digital Application) Clinical Trial Eligibility Overview. Trial Name: NCT04050982 — N/A
Atrial Fibrillation Research Study Groups: Usual Care then AF Care, Pilot Testing, AF CARE plus Usual Care
Atrial Fibrillation Clinical Trial 2023: AF CARE Highlights & Side Effects. Trial Name: NCT04050982 — N/A
AF CARE (Digital Application) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04050982 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current capacity for participants in this research endeavor?

"Yes, clinicaltrials.gov confirms that this research is actively recruiting participants. The trial was initially posted on October 1st 2019 and the information has been revised as recently as April 7th 2021. Sixty individuals must be recruited from a single location for this experiment to take place."

Answered by AI

Are any new participants being enrolled in this clinical exploration?

"Affirmative. According to the information available on clinicaltrials.gov, this medical trial is enrolling participants and was first posted on October 1st 2019 with its most recent edit occuring April 7th 2021. Sixty patients are needed for this study at one location."

Answered by AI
~2 spots leftby Mar 2025